Lexeo Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Lexeo Therapeutics has a total shareholder equity of $183.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $213.2M and $30.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$195.06m |
Equity | US$182.95m |
Total liabilities | US$30.26m |
Total assets | US$213.21m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: LXEO's short term assets ($198.1M) exceed its short term liabilities ($21.6M).
Long Term Liabilities: LXEO's short term assets ($198.1M) exceed its long term liabilities ($8.6M).
Debt to Equity History and Analysis
Debt Level: LXEO is debt free.
Reducing Debt: LXEO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LXEO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: LXEO has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 31.8% each year.